MTOR and neoplasm: Their findings were corroborated by studies using genetically engineered mouse models of lung cancer where an mTOR inhibitor, combined with a PD-1 antibody, reduced tumor growth, increased tumor-infiltrating T cells and diminished regulatory T cells [156].